Tempest Therapeutics, Inc.
TPST
$6.90
$0.294.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.40% | -84.47% | -55.56% | -26.24% | -3.51% |
| Total Depreciation and Amortization | -22.73% | -42.35% | 10.23% | 86.75% | -29.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.26% | 4.39% | 58.97% | 92.87% | 93.88% |
| Change in Net Operating Assets | 190.55% | 675.80% | -66.10% | 940.67% | 31.80% |
| Cash from Operations | -11.83% | -64.36% | -56.96% | 13.80% | 13.45% |
| Capital Expenditure | -- | 57.14% | -- | -112.82% | -265.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 57.14% | -- | -112.82% | -265.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 228.22% | -41.33% | 17,709.52% | 283.59% | 922.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -260.22% | -47.74% | 7,238.10% | 283.59% | 922.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.84% | -72.31% | -33.87% | 77.41% | 16.87% |